VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 229 filers reported holding VERACYTE INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,964 | -14.4% | 11,015 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $287,428 | +9.1% | 11,285 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $263,541 | -3.0% | 11,818 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $271,613 | +1.0% | 11,446 | +17.3% | 0.00% | 0.0% |
| Q1 2022 | $269,000 | -33.1% | 9,755 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $402,000 | -11.3% | 9,755 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $453,000 | +8.1% | 9,755 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $419,000 | -25.7% | 10,475 | -0.3% | 0.00% | -25.0% |
| Q1 2021 | $564,000 | +7.8% | 10,505 | -1.6% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +0.2% | 10,680 | -33.5% | 0.00% | -20.0% |
| Q3 2020 | $522,000 | +16.3% | 16,070 | -7.2% | 0.01% | +25.0% |
| Q2 2020 | $449,000 | +7.7% | 17,325 | +1.1% | 0.00% | -20.0% |
| Q1 2020 | $417,000 | +13.9% | 17,135 | +30.7% | 0.01% | +66.7% |
| Q4 2019 | $366,000 | – | 13,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |